| Info | ||
|---|---|---|
| ||
Date & Time: 13th March 2025, 11am UTC (Online) |
| Info | ||
|---|---|---|
| ||
|
Attendees:
| Info | ||
|---|---|---|
| ||
Link: DEUSG 13th March 2025 Zoom Meeting Link Meeting ID: 83531388789 Passcode: 076324 |
| Info | ||
|---|---|---|
| ||
Passcode: AH7s$SU7 |
Discussion items
**DRAFT**45678Item Description
Mins
Owner
Notes & Actions
1 Opening 2 Welcome & Notification of Recording
2 House Keeping 2 Group Feedback on Alternating time zones proposal: (World Time Buddy)
- March 13th: 11am UTC (online)
- April 9th: 1.30pm CEST / 11.30am UTC (online & in person)
- May: 10pm UTC (online)
- June: 11am UTC (online)
- July: 10pm UTC (online)
Meeting Notes:
- Alternating timelines to be trialed in the months ahead.
3 Discussion Forum 2 Discussion Forum has been set up.
- To support community sharing of queries and updates between meetings.
- Opportunity for community knowledge sharing on implementation.
- Use 'DEUSG' for Category.
- Select 'Watch' on the Discussion Forum page to keep up to date.
Of Interest: SNOMED adding forum platform later this year ('Discourse')
Meeting Notes:
- Nicki will post Patch strength briefing notes to the discussion forum to allow members to share further feedback.
4 Current status of the Drug Model and proposals for modifications 30 Continuation of Agenda Item from 20th Feb:
- Australia Presentation
- Follow on Information from Canada (use-cases)
- Feedback to Irelands Proposal
- How would approach manage salts in biosimilars or differences in SmPC documentation.
- Group Discussion/Comments on three proposals
Meeting Notes:
- Group discussion Australia's and Canada's presentations
- : covering strength representation, subsumption of Clinical Drugs, and additional properties
5 Substances - Concepts in Extensions Overview of Approach:
- xxx
Next Steps for Members:
- xxx
5 Alejandro Lopez Osornio - Work underway to collate list across extensions (MS and non-MS)
Meeting Notes:
- Thanks to all members who submitted lists.
6 Substances - authoring for medicines under evaluation (EMA) 2 Meeting Notes:
- No Update
7 Group discussion - Forum queries 10 All Feedback on forum questions:
- RxNorm - SNOMED Alignment
Meeting Notes:
- Item deferred to April meeting
8 Oslo Preparation 2 Shane Byrnes Seeking proposals for agenda items in Oslo
Meeting Notes:
- Members to reach out to Alejandro and Shane to propose topics for April meetings
9 General Community Updates 2 Open Briefing Note
Inactivation of Active Duplicate Descriptions in the Same Hierarchy
- Relevant to Drug Modelling: basic dose form etc.
- Link to Briefing Note on Confluence HERE
- Feedback by 31st March 2025 to Maria Braithwaite via info@snomed.org
Expo 2025 - Call for Abstracts is Open
- SNOMED CT Expo | SNOMED International
- Call for abstracts is open until 24th April 2025
- Outcome of submissions by 31st May 2025
- Call open for Session Presentations, 10min Lightening Talks, or ePosters
10 AOB 2
| Item | Description | Mins | Owner | Notes & Actions | |
|---|---|---|---|---|---|
| 1 | Opening | 2 | Welcome & Notification of Recording | ||
| 2 | House Keeping | 2 | Group Feedback on Alternating time zones proposal: (World Time Buddy)
Meeting Notes:
| ||
| 3 | Discussion Forum | 2 | Discussion Forum has been set up.
Of Interest: SNOMED adding forum platform later this year ('Discourse') Meeting Notes:
| ||
| 4 | Current status of the Drug Model and proposals for modifications | 30 | Continuation of Agenda Item from 20th Feb:
Meeting Notes:
|
| |
| 5 | Substances - Concepts in Extensions | Overview of Approach:
Next Steps for Members:
| 5 | Alejandro Lopez Osornio |
Meeting Notes:
|
| 6 | Substances - authoring for medicines under evaluation (EMA) | 2 | Meeting Notes:
| ||
| 7 | Group discussion - Forum queries | 10 | All | Feedback on forum questions:
Meeting Notes:
| |
| 8 | Oslo Preparation | 2 | Shane Byrnes | Seeking proposals for agenda items in Oslo Meeting Notes:
| |
| 9 | General Community Updates | 2 | Open Briefing Note Inactivation of Active Duplicate Descriptions in the Same Hierarchy
Expo 2025 - Call for Abstracts is Open
| ||
| 10 | AOB | 2 |
| Attachments |
|---|